Key Takeaway: Jeffrey Rona serves as the chief business and financial officer at Ovid, overseeing corporate strategy and capital formation. He joined Ovid in 2019 as a consulting CFO, contributing to strategic financings, including a collaboration with Angelini. With over 25 years of experience, Rona has held leadership positions in several biopharma firms and has a strong financial background.
Price reaction · baseline $3.64 (2023-09-22 close) · 12 other OVID headline(s) in the window, move may be shared
day 0 close · peak
+2.7%
Market Sentiment Analysis
POSITIVE FACTORS
Jeffrey Rona has over 25 years of experience in the financial sector.
He has successfully assisted Ovid with strategic financings.
His background includes senior leadership roles in various biopharma companies.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+622%
120-day peak, hindsight
Typical move
2.4%
average across 3 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Full Press Release Details
Jeffrey Rona is the chief business and financial officer at Ovid. He is responsible for leading Ovid’s corporate strategy along with the Company’s capital formation with investor groups. Mr. Rona joined Ovid as consulting chief financial officer in 2019 to assist the Company with strategic financings, including Ovid’s collaboration with Angelini. He brings more than 25 years of experience to the role, both as a former investment banker and a strategic financial executive with expertise in financial operations, investor relations and raising capital for public and private companies. He previously held senior leadership positions for GlobeImmune (NASDAQ: GMIB), AlgoRx Pharmaceuticals and Antigenics (NASDAQ: AGEN), and later formed a successful life sciences financial advisory practice. Mr. Rona began his career at Coopers & Lybrand and UBS Investment Bank (NYSE: UBS). He holds a Bachelor of Science in Accounting from Case Western Reserve University.
Frequently Asked Questions
What is Jeffrey Rona's role at Ovid?
Jeffrey Rona is the chief business and financial officer at Ovid.
When did Jeffrey Rona join Ovid?
He joined Ovid in 2019 as a consulting chief financial officer.
What experience does Jeffrey Rona have?
He has over 25 years of experience in financial operations and investor relations.
What companies has Jeffrey Rona worked for?
He has held senior positions at GlobeImmune, AlgoRx Pharmaceuticals, and Antigenics.
Biotech snapshot
Cash runway
$166M liquidity · $5M/mo burn
~33 mo
Minimal dilution risk
Catalyst track record
+622%
best trade around OVID's most recent catalyst
Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for OVID.